Cargando…
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
Fibronectin is a matrix glycoprotein which has not only been found to be over-expressed in several cancers, but has been shown to participate in several steps of tumorigenesis. The purpose of this review is to illustrate how aberrant fibronectin expression influences tumor growth, invasion, metastas...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370511/ https://www.ncbi.nlm.nih.gov/pubmed/28367247 http://dx.doi.org/10.7150/jca.16901 |